Related Experiment Video
Updated: Jun 4, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Apoptosis induced by cytoskeletal disruption requires distinct domains of MEKK1
Erin Tricker1, Afsane Arvand, Raymond Kwan
1Department of Microbiology, Immunology & Molecular Genetics, University of California Los Angeles, Los Angeles, California, United States of America.
Abstract:
MEKK1 is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates the MAPK JNK and is required for microtubule inhibitor-induced apoptosis in B cells. Here, we find that apoptosis induced by actin disruption via cytochalasin D and by the protein phosphatase 1/2A inhibitor okadaic acid also requires MEKK1 activation. To elucidate the functional requirements for activation of the MEKK1-dependent apoptotic pathway, we created mutations within MEKK1. MEKK1-deficient cells were complemented with MEKK1 containing mutations in either the ubiquitin interacting motif (UIM), plant homeodomain (PHD), caspase cleavage site or the kinase domain at near endogenous levels of expression and tested for their sensitivity to each drug. We found that both the kinase activity and the PHD domain of MEKK1 are required for JNK activation and efficient induction of apoptosis by drugs causing cytoskeletal disruption. Furthermore, we discovered that modification of MEKK1 and its localization depends on the integrity of the PHD.
Insights
Mitogen-activated protein kinase kinase kinase 1 (MEKK1) is crucial for apoptosis induced by cytoskeletal disruption. Its kinase activity and Plant Homeodomain (PHD) are essential for activating JNK signaling and cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mitogen-activated protein kinase kinase kinase 1 (MEKK1) is a MAP3K that activates JNK.
- MEKK1 is known to be essential for apoptosis induced by microtubule inhibitors in B cells.
Purpose of the Study:
- To investigate the functional requirements for MEKK1 activation in apoptosis.
- To determine the role of MEKK1 domains in cytoskeletal disruption-induced apoptosis.
Main Methods:
- Created MEKK1 mutations in UIM, PHD, caspase cleavage site, and kinase domains.
- Complemented MEKK1-deficient cells with mutated MEKK1 and tested drug sensitivity.
- Assessed JNK activation and apoptosis induction.
Main Results:
- MEKK1 kinase activity and PHD domain are required for JNK activation and apoptosis.
- Drugs causing cytoskeletal disruption induce apoptosis via MEKK1.
- MEKK1 modification and localization depend on PHD integrity.
Conclusions:
- MEKK1 is a key regulator of apoptosis induced by cytoskeletal disruption.
- Both MEKK1 kinase activity and its PHD domain are critical for this process.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Caspases
Anaphase Promoting Complex
Apoptosis
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...

